Komori
Ivy Cosmetics (4918) · RiskMitigated

Deterioration in Operating Cash Flow and Decline in Cash Liquidity

First written in FY2018. 16 of 29 entries say "Mitigated", first in FY2019-Q3. Latest entry: FY2026.

29entries
9years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorse2018: 220182019: 420192020: 320202021: 420212022: 420222023: 420232024: 320242025: 220252026: 32026
Same theme, other companies
Changes in cash balances accompanying a decrease in cash flow from operating activitiesA theme 267 companies write about · 113 as a headwind · 123 as a tailwind

13 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 190 companies compared. The sentences above are computed from all 190.Comparing 200 of the theme's 278 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026MitigatedAnnual report

    「During the fiscal year, operating cash flow was positive at ¥451.036 million. Investing cash flow was negative, while financing cash flow was positive. Cash and cash equivalents at the fiscal year-end stood at ¥1,041.445 million, up ¥463.508 million from the end of the previous fiscal year.」

    Liquidity on hand continued to improve from the previous year due to positive operating cash flow and an increase in cash and cash equivalents. Meanwhile, the policy of curbing purchases and expenses and increasing liquidity remains in place.
  2. FY2026-H1Decrease in cash and cash equivalents and continued policy of securing cash on handAnnual report

    「Cash and cash equivalents at the end of the interim accounting period stood at ¥451.663 million, down ¥126.274 million from the end of the previous fiscal year. Going forward, the Company will prioritize securing cash on hand while increasing sales and curbing purchases and expenses.」

    Cash and cash equivalents declined from the previous fiscal year-end, and securing cash on hand remains an ongoing priority. Meanwhile, cash and cash equivalents increased substantially from ¥66.413 million in the interim period of the previous year.
  3. FY2025MitigatedAnnual report

    「During the fiscal year, operating cash flow was positive at ¥455.936 million. Although investing and financing cash flow were negative, cash and cash equivalents stood at ¥577.937 million at the end of the fiscal year, up ¥369.204 million from the end of the previous fiscal year.」

    Liquidity on hand improved from the previous fiscal year-end due to positive operating cash flow and an increase in cash and cash equivalents. However, the policy of increasing liquidity remains in place.
  4. FY2025-H1WorsenedAnnual report

    「Cash and cash equivalents at the end of the interim accounting period stood at ¥66.413 million, down ¥142.319 million from the end of the previous fiscal year. Selling, general and administrative expenses decreased by ¥73.902 million from the previous interim accounting period, and expense reduction efforts continue to progress smoothly. Going forward, the Company will prioritize securing cash on hand while increasing sales and curbing purchases and expenses.」

    Although expense reductions progressed, cash and cash equivalents fell by ¥142.319 million from the previous fiscal year-end to ¥66.413 million, making the securing of liquidity on hand an important challenge once again.
  5. FY2024Improvement in operating cash flow alongside a decrease in cash balanceAnnual report

    「During the fiscal year, operating cash flow turned positive at ¥453 million. Although financing cash flow was negative, cash and cash equivalents at the fiscal year-end stood at ¥208 million, down ¥38 million from the end of the previous fiscal year. Going forward, the Company plans to increase sales, curb purchases and expenses, and increase liquidity on hand.」

    Although operating cash flow turned positive, cash and cash equivalents declined, and increasing liquidity on hand by curbing purchases and expenses remains an ongoing challenge.
  6. FY2024-Q3MitigatedAnnual report

    「Cash and cash equivalents at the end of the third quarter stood at ¥516.855 million, up ¥269.184 million from the end of the previous fiscal year. Selling, general and administrative expenses decreased by ¥317.297 million from the cumulative period of the same quarter of the previous year, and expense reduction efforts are progressing smoothly. Going forward, the Company will prioritize securing cash on hand while increasing sales and curbing purchases and expenses.」

    Cash and cash equivalents increased by ¥269.184 million from the end of the previous fiscal year, while selling, general and administrative expenses decreased by ¥317.297 million from the same period of the previous year. Securing cash on hand and curbing purchases and expenses remain ongoing priorities.
  7. FY2024-Q2Slight decrease in cash and cash equivalents and continued efforts to secure cash on handAnnual report

    「Cash and cash equivalents at the end of the second quarter stood at ¥240.541 million, down ¥7.129 million from the end of the previous fiscal year. Going forward, the Company will prioritize securing cash on hand while increasing sales and curbing purchases and expenses.」

    Although operating cash flow improved, cash and cash equivalents fell by ¥7.129 million from the end of the previous fiscal year, and the Company continues to prioritize securing cash on hand by curbing purchases and expenses.
  8. FY2024-Q1MitigatedAnnual report

    「Cash and cash equivalents at the end of the first quarter stood at ¥361.033 million, up ¥113.363 million from the end of the previous fiscal year.」

    Cash and cash equivalents increased by ¥113.363 million from the end of the previous fiscal year to ¥361.033 million. The Company continues its policy of securing cash on hand and improving its financial position through higher sales, expense reductions, and curbing purchases.
  9. FY2023MitigatedAnnual report

    「During the fiscal year, operating cash flow turned positive at ¥278 million. Although investing and financing cash flows were negative, cash and cash equivalents at the fiscal year-end stood at ¥247 million, up ¥118 million from the end of the previous fiscal year.」

    Operating cash flow turned positive, and cash and cash equivalents increased from ¥129 million to ¥247 million. However, curbing purchases and expenses and increasing cash on hand remain ongoing challenges.
  10. FY2023-Q3MitigatedAnnual report

    「Cash and cash equivalents at the end of the third quarter stood at ¥291.474 million, up ¥162.090 million from the end of the previous fiscal year. Although distributors were affected by the COVID-19 pandemic, they maintained their tenacious sales capabilities. Cash positions across the sales organization improved through government support, including benefits, and trade receivables were collected almost smoothly.」

    Cash and cash equivalents rose by ¥162.090 million from the end of the previous fiscal year to ¥291.474 million, and trade receivables were collected almost smoothly. The Company continues its policy of increasing liquidity on hand and curbing expenses and purchases.
  11. FY2023-Q2WorsenedAnnual report

    「Cash and cash equivalents at the end of the second quarter stood at ¥77.716 million, down ¥51.668 million from the end of the previous fiscal year.」

    Cash and cash equivalents fell by ¥51.668 million from the end of the previous fiscal year to ¥77.716 million, and the Company states that securing liquidity on hand remains a priority.
  12. FY2023-Q1MitigatedAnnual report

    「Cash and cash equivalents at the end of the first quarter stood at ¥190.294 million, up ¥60.910 million from the end of the previous fiscal year.」

    Cash and cash equivalents increased from ¥129.384 million at the end of the previous fiscal year to ¥190.294 million. However, the Company continues to prioritize securing cash on hand and improving its financial position by curbing purchases and expenses.
  13. FY2022Coexistence of an increase in cash and cash equivalents and negative operating cash flowAnnual report

    「During the fiscal year, operating cash flow was negative while investing and financing cash flows were positive, and cash and cash equivalents at the fiscal year-end stood at ¥129 million, up ¥113 million from the end of the previous fiscal year.」

    Although cash and cash equivalents increased, operating cash flow was negative at ¥107 million, and increasing liquidity on hand remains an ongoing challenge.
  14. FY2022-Q3MitigatedAnnual report

    「Cash and cash equivalents at the end of the third quarter stood at ¥359.737 million, up ¥246.307 million from the end of the previous fiscal year. Although sales activities at distributors were restricted by the COVID-19 pandemic and the resulting state of emergency, the distributors maintained their tenacious sales capabilities. Cash positions across the sales organization also improved through government support, including sustainability benefits, and trade receivables were collected smoothly.」

    Cash and cash equivalents increased by ¥246.307 million from the end of the previous fiscal year, and trade receivables were also collected smoothly. The Company states that it has secured the necessary funding with the cooperation of its relationship banks, but continues to pursue a policy of increasing liquidity on hand.
  15. FY2022-Q2WorsenedAnnual report

    「Cash and cash equivalents at the end of the second quarter stood at ¥24.027 million, down ¥89.402 million from the end of the previous fiscal year.」

    Although sales recovered and the Company reported a profit, cash and cash equivalents fell to ¥24.027 million, and increasing liquidity on hand remains an ongoing challenge.
  16. FY2022-Q1MitigatedAnnual report

    「Cash management is also improving, partly because the first series of stock acquisition rights was exercised.」

    The Company states that cash management is improving through proceeds from the exercise of stock acquisition rights, collection of trade receivables, and expense reductions. Cash and cash equivalents also increased by ¥303.244 million from the end of the previous fiscal year.
  17. FY2021MitigatedAnnual report

    「Although operating and investing cash flows were positive during the fiscal year, financing cash flow was negative, and cash and cash equivalents at the fiscal year-end stood at ¥113 million, up ¥68 million from the end of the previous fiscal year.」

    Operating and investing cash flows were positive, and cash and cash equivalents increased by ¥68 million from the previous fiscal year-end, but increasing cash on hand remains an ongoing challenge.
  18. FY2021-Q3MitigatedAnnual report

    「Cash and cash equivalents at the end of the third quarter stood at ¥304.602 million, up ¥259.856 million from the end of the previous fiscal year.」

    The Company states that cash management gradually improved, supported by the sale of investment property, tax and other payment deferrals, and borrowing through safety-net programs, while cash and cash equivalents increased by ¥259.856 million from the end of the previous fiscal year.
  19. FY2021-Q2MitigatedAnnual report

    「Selling, general and administrative expenses decreased by ¥360.360 million from the cumulative period of the same quarter of the previous year. In addition, cash management is gradually improving as the Company sold investment property and was granted tax and other payment deferrals and loans through safety-net programs under government measures addressing COVID-19.」

    The Company states that cash management gradually improved through expense reductions, the sale of investment property, tax and other payment deferrals, and borrowing through safety-net programs. Cash and cash equivalents also increased by ¥127.107 million from the end of the previous fiscal year.
  20. FY2021-Q1RestatedAnnual report

    「However, cash and cash equivalents at the end of the first quarter stood at ¥82 million. Including trade receivables of ¥682 million, readily available funds were below the level the Company considers safe. The Company will continue reducing inventories and expenses, work to improve cash flow, and reduce debt.」

    Although cash and cash equivalents increased by ¥37.289 million from the end of the previous fiscal year, the Company continues to recognize that readily available funds, consisting of ¥82 million in cash and cash equivalents plus ¥682 million in trade receivables, remain below a safe level.
  21. FY2020-Q3WorsenedAnnual report

    「Cash and cash equivalents at the end of the third quarter stood at ¥393.802 million, down ¥465.953 million from the end of the previous fiscal year. The Company plans to continue curbing purchases and expenses to secure liquidity on hand.」

    Cash and cash equivalents fell by ¥465.953 million from the end of the previous fiscal year, and securing liquidity on hand remains necessary.
  22. FY2020-Q2WorsenedAnnual report

    「Cash and cash equivalents at the end of the second quarter stood at ¥84.416 million, down ¥775.339 million from the end of the previous fiscal year. The Company plans to continue curbing purchases and expenses to secure liquidity on hand.」

    Although the Company returned to profitability, cash and cash equivalents fell by ¥775.339 million from the end of the previous fiscal year to ¥84.416 million, and securing liquidity on hand remains necessary.
  23. FY2020-Q1WorsenedAnnual report

    「The company will continue to restrain purchases and expenses and build up cash liquidity. It will make every effort to improve its financial position, which deteriorated in prior fiscal years and during the first quarter.」

    Cash and deposits at the end of the first quarter totaled ¥588.531 million, down ¥271.225 million from the end of the previous fiscal year, indicating a continued need to build up cash liquidity.
  24. FY2019MitigatedAnnual report

    「All operating, investing and financing cash flows were positive during the fiscal year, and cash and deposits at the end of the fiscal year totaled ¥859 million, an increase of ¥696 million from the end of the previous fiscal year.」

    Operating, investing and financing cash flows were all positive, and cash and deposits increased from ¥163 million to ¥859 million.
  25. FY2019-Q3MitigatedAnnual report

    「To maintain a sound financial position, the company determined that equity-like funding was necessary and issued ¥1,000.000 million of bond-type preferred shares through a third-party allotment in December. As a result, the equity ratio improved to 26.0%, and cash flow conditions also improved.」

    The company raised ¥1,000.000 million in equity-like funding, improving the equity ratio to 26.0% and making progress in addressing deteriorating cash flow.
  26. FY2019-Q2WorsenedAnnual report

    「To address the decline in net assets and deterioration in cash flow, the company will improve the earnings situation described above, secure funding sources that do not rely solely on asset sales or bank borrowings, and take the necessary measures to prevent year-end financial metrics from breaching covenant agreements, thereby maintaining a sound financial base.」

    Net assets totaled ¥873.639 million, the equity ratio was 15.6%, and cash and cash equivalents totaled ¥195.418 million. The company identified securing funding sources other than asset sales and bank borrowings as a response to deteriorating cash flow.
  27. FY2018First statedAnnual report

    「The company expects its cash position to improve going forward and plans to build up cash on hand by restraining purchases and expenses. The group will make every effort to improve its financial position, which deteriorated during the consolidated fiscal year.」

    Cash and cash equivalents totaled ¥163.899 million and operating cash flow was negative ¥2,127.217 million, creating an actual need to build up cash liquidity.
Moved together

"Strengthening the earnings base through lower manufacturing costs, minimized fixed costs, and effective use of assets" moved the same way as this thread, in the same document, in 12 of its 29 moves.

1212111088★123456
  1. ★This thread
  2. 1Strengthening the earnings base through lower manufacturing costs, minimized fixed costs, and effective use of assets12×
  3. 2Raising Working Capital through Bank-Guaranteed Privately Placed Bonds12×
  4. 3Financial Condition of Sales Organizations and Sharp Changes in Channel Inventory11×
  5. 4Building a High-Performance Product Portfolio Centered on Serums10×
  6. 5Raising Funds for New Product Development and Marketing through a Third-Party Allotment of Stock Acquisition Rights8×
  7. 6Significant Doubt Regarding Going Concern and Remedial Measures8×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Ivy Cosmetics yet. It last moved in the Earnings of 2026-05-14: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Deterioration in Operating Cash Flow and Decline in Cash Liquidity | IVY COSMETICS CORPORATION (4918) | Komori